WESHIELD is a premier medical supply distribution company providing bulk wholesale COVID-19 test kits for many of the most trusted institutions and organizations in the world.

We currently provide Abbott BinaxNOW, Realy Tech, QuickVue, CareStart, Celtrion Diatrust and FlowFlex COVID-19 Test kits.

Call now us now at (800) 499-1182 or fill out the form below to find out how WESHIELD can cut costs, improve lead times, and support your compliance and supply chain processes.

WESHIELD inventories a wide range of COVID-19 test kits (rapid, antigen, antibody, brands, grades, etc.) to meet all needs and requirements. See some of our most popular COVID-19 test kits below.



Realy Tech Prepared COVID-19 Rapid Antibody Test

The 2019-nCOV/COVID-19 IgG/IgM Rapid Test Device is a rapid chromatographic immunoassay for the qualitative detection of IgG&IgM antibody of Coronavirus Disease 2019 in human whole blood,serum,or plasma as an aid in the diagnosis of COVID-19 infections.

BinaxNOW COVID-19 Ag Card

The BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitativedetection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabsfrom individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset. 

The 15-minute BinaxNOW™ COVID-19 Ag Card Home Test has received FDA Emergency Use Authorization for at-home testing in collaboration with eMed, a digital health solution. This first-of-its kind service for COVID-19 testing  prescribes and ships the test directly to your home. A trained telehealth professional then guides you through the at-home self-test via video call using the BinaxNOW COVID-19 Ag Card Home Test and Abbott’s complementary NAVICA™ mobile app to enable the testing process and display BinaxNOW COVID-19 test results. 



CareStart COVID-19 Antigen Test

The CareStart™ COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.


QuickVue At-Home COVID-19 Test

QuickVue At-Home OTC COVID-19 Test lets you get rapid results, in the privacy of your own home. Available over-the-counter, everything you need is in the package and taking the test is simple.

The test is authorized for home use with self-collected anterior nasal (nares) swab samples in individuals aged 2 and older. This test is also authorized for home use for individuals aged 2 through 14 with an adult performing the test. The test is intended to be used twice over two to three days, with at least 24 hours and no more than 36 hours between tests.

Request COVID-19 Test Pricing, Product Information, Lead-Times and more.